Response of patients with locally advanced pancreatic adenocarcinoma to high-intensity focused ultrasound treatment: a single-center, prospective, case series in China

References

• SiegelRLMillerKDJemalACancer statistics, 2018CA Cancer J Clin201868173029313949
   PubMed Web of Science ®Google Scholar
• ChenWZhengRBaadePDCancer statistics in China, 2015CA Cancer J Clin201666211513226808342
   PubMed Web of Science ®Google Scholar
• HeestandGMMurphyJDLowyAMApproach to patients with pancreatic cancer without detectable metastasesJ Clin Oncol201533161770177825918279
   PubMed Web of Science ®Google Scholar
• HsuehCTPancreatic cancer: current standards, research updates and future directionsJ Gastrointest Oncol20112312312522811841
   PubMedGoogle Scholar
• YamadaSFujiiTYokoyamaYPhase I study of chemoradiotherapy using gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic cancerCancer Chemother Pharmacol201881581582129502139
   PubMed Web of Science ®Google Scholar
• EvansTRJVan CutsemEMooreMJPhase 2 placebo-controlled, double-blind trial of dasatinib added to gemcitabine for patients with locally-advanced pancreatic cancerAnn Oncol201728235436127998964
   PubMed Web of Science ®Google Scholar
• GhosnMFarhatFKattanJFOLFOX-6 combination as the first-line treatment of locally advanced and/or metastatic pancreatic cancerAm J Clin Oncol2007301152017278889
   PubMed Web of Science ®Google Scholar
• GhosnMSaroufimAKattanJChahineGNasrFFarhatFSequential FOLFOX-6 and gemcitabine for locally advanced and/or metastatic pancreatic cancerMed Oncol20122942831283722392197
   PubMed Web of Science ®Google Scholar
• LakatosGPetranyiASzűcsAEfficacy and Safety of FOL-FIRINOX in Locally Advanced Pancreatic Cancer. A Single Center ExperiencePathol Oncol Res201723475375928062950
   PubMed Web of Science ®Google Scholar
• SukerMBeumerBRSadotEFOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysisLancet Oncol201617680181027160474
   PubMed Web of Science ®Google Scholar
• NyweningTMWang-GillamASanfordDETargeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trialLancet Oncol201617565166227055731
   PubMed Web of Science ®Google Scholar
• SultanaASmithCTCunninghamDStarlingNNeoptolemosJPGhanehPMeta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancerJ Clin Oncol200725182607261517577041
   PubMed Web of Science ®Google Scholar
• OrsiFArnonePChenWZhangLHigh intensity focused ultrasound ablation: a new therapeutic option for solid tumorsJ Cancer Res Ther20106441442021358073
   PubMed Web of Science ®Google Scholar
• ZhouYHigh-intensity focused ultrasound treatment for advanced pancreatic cancerGastroenterol Res Pract2014205325
   Web of Science ®Google Scholar
• WuFHigh intensity focused ultrasound: a noninvasive therapy for locally advanced pancreatic cancerWorld J Gastroenterol20142044164801648825469016
   PubMed Web of Science ®Google Scholar
• OrsiFZhangLArnonePHigh-intensity focused ultrasound ablation: effective and safe therapy for solid tumors in difficult locationsAJR Am J Roentgenol20101953W245W25220729423
   PubMed Web of Science ®Google Scholar
• WuFWangZBZhuHFeasibility of US-guided high-intensity focused ultrasound treatment in patients with advanced pancreatic cancer: initial experienceRadiology200523631034104016055692
   PubMed Web of Science ®Google Scholar
• WangKChenZMengZAnalgesic effect of high intensity focused ultrasound therapy for unresectable pancreatic cancerInt J Hyperthermia201127210110721219135
   PubMed Web of Science ®Google Scholar
• SungHYJungSEChoSHLong-term outcome of high-intensity focused ultrasound in advanced pancreatic cancerPancreas20114071080108621926543
   PubMed Web of Science ®Google Scholar
• WangKZhuHMengZSafety evaluation of high-intensity focused ultrasound in patients with pancreatic cancerOnkologie2013363889223485995
   PubMedGoogle Scholar
• GaoHFWangKMengZQHigh intensity focused ultrasound treatment for patients with local advanced pancreatic cancerHepatogastroenterology2013601281906191024088318
   PubMedGoogle Scholar
• ZhaoHYangGWangDConcurrent gemcitabine and high-intensity focused ultrasound therapy in patients with locally advanced pancreatic cancerAnticancer Drugs201021444745220075714
   PubMed Web of Science ®Google Scholar
• LiYJHuangGLSunXLZhaoXCLiZGThe combination therapy of high-intensity focused ultrasound with radiotherapy in locally advanced pancreatic carcinomaWorld J Surg Oncol2016146026927794
   PubMed Web of Science ®Google Scholar
• TherassePArbuckSGEisenhauerEANew guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of CanadaJ Natl Cancer Inst200092320521610655437
   PubMed Web of Science ®Google Scholar
• LiuYJZhuGPGuanXYComparison of the NCI-CTCAE version 4.0 and version 3.0 in assessing chemoradiation-induced oral mucositis for locally advanced nasopharyngeal carcinomaOral Oncol201248655455922289637
   PubMed Web of Science ®Google Scholar
• SofuniAMoriyasuFSanoTThe current potential of high-intensity focused ultrasound for pancreatic carcinomaJ Hepatobiliary Pancreat Sci201118329530321360084
   PubMed Web of Science ®Google Scholar
• HwangJHWangYNWarrenCPreclinical in vivo evaluation of an extracorporeal HIFU device for ablation of pancreatic tumorsUltrasound Med Biol200935696797519201519
   PubMed Web of Science ®Google Scholar
• WuFZhouLChenWRHost antitumour immune responses to HIFU ablationInt J Hyperthermia200723216517117578340
   PubMed Web of Science ®Google Scholar
• LiuFHuZQiuLBoosting high-intensity focused ultrasound-induced anti-tumor immunity using a sparse-scan strategy that can more effectively promote dendritic cell maturationJ Transl Med20108720105334
   PubMed Web of Science ®Google Scholar
• RanLFXieXPXiaJZXieFLFanYMWuFSpecific antitumour immunity of HIFU-activated cytotoxic T lymphocytes after adoptive transfusion in tumour-bearing miceInt J Hyperthermia201632220421026708472
   PubMed Web of Science ®Google Scholar
• Vidal-JoveJPerichEDelCastillo MAUltrasound Guided High Intensity Focused Ultrasound for malignant tumors: The Spanish experience of survival advantage in stage III and IV pancreatic cancerUltrason Sonochem20152770370626044461
   PubMed Web of Science ®Google Scholar
• GeHYMiaoLYXiongLLHigh-intensity focused ultrasound treatment of late-stage pancreatic body carcinoma: optimal tumor depth for safe ablationUltrasound Med Biol201440594795524462161
   PubMed Web of Science ®Google Scholar
• SpanoJPChodkiewiczCMaurelJEfficacy of gemcitabine plus axitinib compared with gemcitabine alone in patients with advanced pancreatic cancer: an open-label randomised phase II studyLancet200837196302101210818514303
   PubMed Web of Science ®Google Scholar
• BoradMJReddySGBaharyNRandomized Phase II Trial of Gemcitabine Plus TH-302 Versus Gemcitabine in Patients With Advanced Pancreatic CancerJ Clin Oncol201533131475148125512461
   PubMed Web of Science ®Google Scholar
• CunninghamDChauIStockenDDPhase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancerJ Clin Oncol200927335513551819858379
   PubMed Web of Science ®Google Scholar
• LoehrerPJSrFengYCardenesHGemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group trialJ Clin Oncol201129314105411221969502
   PubMed Web of Science ®Google Scholar
• ColucciGLabiancaRDi CostanzoFRandomized phase III trial of gemcitabine plus cisplatin compared with single-agent gemcitabine as first-line treatment of patients with advanced pancreatic cancer: the GIP-1 studyJ Clin Oncol201028101645165120194854
   PubMed Web of Science ®Google Scholar
• GonçalvesAGilabertMFrançoisEBAYPAN study: a double-blind phase III randomized trial comparing gemcitabine plus sorafenib and gemcitabine plus placebo in patients with advanced pancreatic cancerAnn Oncol201223112799280522771827
   PubMed Web of Science ®Google Scholar
• PhilipPABenedettiJCorlessCLPhase III study comparing gemcitabine plus cetuximab versus gemcitabine in patients with advanced pancreatic adenocarcinoma: Southwest Oncology Group-directed intergroup trial S0205J Clin Oncol201028223605361020606093
   PubMed Web of Science ®Google Scholar
• MarinovaMRauchMMückeMHigh-intensity focused ultrasound (HIFU) for pancreatic carcinoma: evaluation of feasibility, reduction of tumour volume and pain intensityEur Radiol201626114047405626886904
   PubMed Web of Science ®Google Scholar
• ZhaoJZhaoFShiYDengYHuXShenHThe efficacy of a new high intensity focused ultrasound therapy for locally advanced pancreatic cancerJ Cancer Res Clin Oncol2017143102105211128620685
   PubMed Web of Science ®Google Scholar
• Moureau-ZabottoLPhélipJMAfchainPConcomitant administration of weekly oxaliplatin, fluorouracil continuous infusion, and radiotherapy after 2 months of gemcitabine and oxaliplatin induction in patients with locally advanced pancreatic cancer: a Groupe Coordinateur Multidisciplinaire en Oncologie phase II studyJ Clin Oncol20082671080108518309942
   PubMed Web of Science ®Google Scholar
• MahadevanAJainSGoldsteinMStereotactic body radiotherapy and gemcitabine for locally advanced pancreatic cancerInt J Radiat Oncol Biol Phys201078373574220171803
   PubMed Web of Science ®Google Scholar
• MarinovaMHuxoldHCHenselerJClinical Effectiveness and Potential Survival Benefit of US-Guided High-Intensity Focused Ultrasound Therapy in Patients with Advanced-Stage Pancreatic CancerUltraschall Med Epub2018417
   Web of Science ®Google Scholar
• XiongLLHwangJHHuangXBEarly clinical experience using high intensity focused ultrasound for palliation of inoperable pancreatic cancerJOP200910212312919287104
   PubMedGoogle Scholar
• LiPZZhuSHHeWHigh-intensity focused ultrasound treatment for patients with unresectable pancreatic cancerHepatobiliary Pancreat Dis Int201211665566023232639
   PubMed Web of Science ®Google Scholar